These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9732528)

  • 1. Overexpression of a mutant B subunit in toxigenic Vibrio cholerae diminishes production of active cholera toxin in vivo.
    Silva A; Fando R; Benitez JA
    Curr Microbiol; 1998 Oct; 37(4):231-5. PubMed ID: 9732528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
    Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B
    Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.
    Sanchez J; Holmgren J
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):481-5. PubMed ID: 2492108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.
    Rhie GE; Jung HM; Kim BS; Mekalanos JJ
    Vaccine; 2008 Oct; 26(43):5443-8. PubMed ID: 18582519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
    Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
    Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines.
    Lebens M; Johansson S; Osek J; Lindblad M; Holmgren J
    Biotechnology (N Y); 1993 Dec; 11(13):1574-8. PubMed ID: 7764248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.
    Boustanshenas M; Bakhshi B; Ghorbani M
    J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Expression of CTB in
    Choi H; Son S; Lee D; Bae J; Seo E; Kim DW; Kim EJ
    J Microbiol Biotechnol; 2023 Jun; 33(6):736-744. PubMed ID: 37072680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains.
    Butterton JR; Boyko SA; Calderwood SB
    Vaccine; 1993 Oct; 11(13):1327-35. PubMed ID: 8296486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of cholera toxin subunit B by a mutant strain of Vibrio cholerae.
    van de Walle M; Fass R; Shiloach J
    Appl Microbiol Biotechnol; 1990 Jul; 33(4):389-94. PubMed ID: 1366742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of an auxotrophic ctxA mutant of O139 Vibrio cholerae.
    Chan M; Cheong TG; Kurunathan S; Chandrika M; Ledon T; Fando R; Lalitha P; Zainuddin ZF; Ravichandran M
    Microb Pathog; 2010 Nov; 49(5):211-6. PubMed ID: 20558271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis].
    Smirnova NI; Krepostnova IM; Livanova LF; Zadnova SP; Eremin SA; Il'ina TS
    Mol Gen Mikrobiol Virusol; 2007; (4):7-13. PubMed ID: 18154075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin.
    Fontana MR; Monaci E; Yanqing L; Guoming Q; Duan G; Rappuoli R; Pizza M
    Vaccine; 2000 Aug; 19(1):75-85. PubMed ID: 10924789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis.
    Ichikawa Y; Yamagata H; Tochikubo K; Udaka S
    FEMS Microbiol Lett; 1993 Aug; 111(2-3):219-24. PubMed ID: 8405930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of a thyA mutant derived from cholera vaccine candidate IEM101.
    Yu F; Qi G; Liu Y; Gao S; Kan B
    Mol Biotechnol; 2005 Mar; 29(3):191-6. PubMed ID: 15767696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous antigen expression in Vibrio cholerae vector strains.
    Butterton JR; Beattie DT; Gardel CL; Carroll PA; Hyman T; Killeen KP; Mekalanos JJ; Calderwood SB
    Infect Immun; 1995 Jul; 63(7):2689-96. PubMed ID: 7790086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum).
    Sharma MK; Singh NK; Jani D; Sisodia R; Thungapathra M; Gautam JK; Meena LS; Singh Y; Ghosh A; Tyagi AK; Sharma AK
    Plant Cell Rep; 2008 Feb; 27(2):307-18. PubMed ID: 17962948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The capacity to produce cholera exotoxin in natural strains of Vibrio cholerae].
    Smirnova NI; Livanova LF; Eroshenko GA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Mar; (3):6-10. PubMed ID: 2195813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.